Rx only · Injection, Solution · Subcutaneous
Bimekizumab
Brands: Bimzelx · Bimekizumab
1 ACTIVE SUPPLIER - US
openFDA · updated weekly
US4 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
$8054.565
Latest avg · Aug 19, 2026
+5%
Since Dec 17, 2025
1
Active US suppliers